Hexanitrogen Energies(science.org)
21 points by thomasjb | 6 comments
21 points by thomasjb | 6 comments
62 points by nick__m | 11 comments
35 points by etiam | 16 comments
68 points by kumarski | 17 comments
399 points by jbm | 211 comments
Derek Lowe's In the Pipeline blog post at Science on Novo Nordisk's mistake in letting its semaglutide patent lapse in Canada, opening the door to generics like Sandoz.